Coumarin dopamine D4 receptor antagonists
US5922719A · kind A · utility
1Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 1997 |
| Grant date | Jul 13, 1999 |
| Priority date | — |
| Expiry date | Aug 11, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds that are antagonists of dopamine D4 receptors, to methods of treating psychosis and schizophrenia using a compound that is an antagonist of dopamine D4 receptors, and to pharmaceutically acceptable compositions that contain a dopamine D4 receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.